A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth
This study is currently recruiting participants.
Verified February 2012 by KV Pharmaceutical Company
Sponsor:
KV Pharmaceutical Company
Collaborator:
Registrat-Mapi
Information provided by (Responsible Party):
KV Pharmaceutical Company
ClinicalTrials.gov Identifier:
NCT01146990
First received: June 16, 2010
Last updated: February 29, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2016 |
| Estimated Primary Completion Date: | June 2016 (Final data collection date for primary outcome measure) |